Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.65) by 4.62 percent. This is a 134.25 percent decrease over earnings of $1.81 per share from the same period last year.
Palo Alto Networks, HCL Technologies Announce Expanded Relationship To Secure Digital And Cloud Transformation For Global Customers
Palo Alto Networks (NASDAQ:PANW), the global cybersecurity leader, and HCL Technologies, the global market leader in next-generation technology and IT services, today announced an expansion of their collaboration to
